SEATTLE, July 27, 2021, (MEDGADGET) — Sarcopenia refers to loss of flesh or skeletal muscle mass loss by aging. Sarcopenia is related to functional tasks impairments such as lifting ten pounds or standing up along with physical disabilities including not being able to carry out home chores and ensure personal care. Past the age of 60 to 70 years, there may be rapid progress in muscle tissue loss, however the precise decline may vary. A person may lose 3% to 8% muscle mass every 10 years. Sarcopenia symptoms include muscle size reduction, weakness, endurance loss, poor balance, and difficulty to climb stairs. There is not any approved treatment accessible for sarcopenia, however dietary supplements and nutrition can be vital IITS treatment. Nutrition impedes increased muscle loss throughout muscle disuse along with maintaining energy levels. Certain important supplements to treat sarcopenia are amino acids, proteins, creatine, vitamin D, omega 3 acid, calcium carbonate and vitamin B12.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2770
Global Sarcopenia Treatment Market – Drivers
Rise in geriatric population is expected to propel growth of the global sarcopenia treatment market. As per the World Health Organization (WHO), the global population aged 60 years and above is predicted to reach from 900 mn in 2015 to 2 bn in 2050. The foundations held meetings, conferences helps in expanding and sharing the information and knowledge regarding sarcopenia treatment is expected to drive the global sarcopenia treatment market growth. For instance, the U.S. Food and Drug Administration (FDA), in April 2017, held Patient Focused Drug Development (PFDD), a public meeting on sarcopenia. The meeting emphasized on obtaining the patient’s perspective on daily impacts and symptoms of their conditions.
Increasing production investments in supplements and drugs are expected to bolster the global sarcopenia treatment market growth. Moreover, food processing and pharmaceutical companies are increasingly emphasizing on development of nutrition supplements to treat sarcopenia. For instance, Nestle, in February 2016, announced its strategic investment in Pronutria Biosciences worth US$ 42.5 million. Pronutria Biosciences will be using Nestlé’s cash to produce a novel compound known as PN-107, which can potentially tackle muscle loss due to prolonged bed rest, aging. Factors of such kind are expected to accelerate the sarcopenia treatment market growth.
Vitamin deficiency and malnutrition in developing nations is expected to register robust growth in the global sarcopenia treatment market. Reduction in the rate of hormone secretion along with rising vitamin deficiency due to aging are expected to accelerate demand for supplements of sarcopenia treatment. Economic factors including increasing consumer expenditure by the geriatric populace, and rise in the expenditure of per capita healthcare are expected to generate demand for supplements of sarcopenia treatment. As per the National Health Expenditure Accounts (NHEA), the expenditure of U.S. health care in 2016 reached US$3.3 trillion, growing up to 4.3%, meaning US$10,348 per capita.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Flat Instant discount of US$ 2000
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2770
However, lack of novel developments to treat sarcopenia are expected to restrain the growth of the global sarcopenia treatment market. Moreover, lack of latest drugs is expected to hamper growth of the global sarcopenia treatment market during the forecast period.
Global Sarcopenia Treatment Market – Regional Analysis
North America is expected to gain a dominant share in the global sarcopenia treatment market, due to the presence of advanced healthcare infrastructure and facilities in countries including Canada and the U.S. Moreover, owing to governments laying high emphasis on healthcare, the demand for sarcopenia treatment has risen in the region due to high focus on healthcare by the government. Technological advancements of such kind are expected to propel the global sarcopenia treatment market growth over the forecast period.
Europe is expected to hold the second dominant position in the global sarcopenia treatment market during the forecast period. For instance, a company based in Paris (France) focused on developing novel therapeutics for diseases associated with age – Biophytis SA, in February 2019, declared three oral as well as poster presentations at the International Conference on Frailty and Sarcopenia Research (ICFSR) 2019. The firm presented details of their lead candidate of clinical drug, Sarconeos (BIO 101), which consisted of its history as well as unique mechanism targeting MAS receptor to preserve muscle function in the disorder of muscle wasting. Furthermore, the company even presented the design for clinical trial of its current SARA Phase 2 study of Sarconeos for the treatment of sarcopenia.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2770
Global Sarcopenia Treatment Market – Key Players
Key players functioning in the sarcopenia treatment market are GlaxoSmithKline, Five Prime Therapeutics, Inc., Radius Health Inc., Abbott Laboratories, Nestle S.A., Pfizer Inc., Sanofi S.A., Novartis AG, Cadila Healthcare Ltd and Bayer AG.
Global Sarcopenia Treatment Market – Taxonomy
Based on treatment type:
- Vitamin B12 Supplement
- Vitamin D and Calcium Supplement
- Protein Supplement
Based on distribution channel:
- Online pharmacies
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- Hypermarket and Supermarket
Based on region:
- North America
- Latin America
- Asia Pacific
- Middle East
Table of Content
Global Sarcopenia Treatment Market Research Report
Section 1: Global Sarcopenia Treatment Industry Overview
Section 2: Global Economic Impact on Sarcopenia Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Sarcopenia Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Sarcopenia Treatment Market Forecast
Other Exclusive Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027